pain-management-2017-posters-accepted-abstracts

6 / 23

Page 52
conferenceseries.com
Volume 6, Issue 5 (Suppl) J Pain Relief, an open access journal
ISSN: 2167-0846 Pain Management 2017
October 05-06, 2017
5th International Conference and Exhibition on
October 05-06, 2017 London, UK
Pain Research And Management
A balanced low FODMAP diet is effective in treating fibromyalgia patients - reducing pain and
improving life-quality
Cátia Moreira1, Ana P Marum2, Pablo Tomas Carus3,4, Fernando Saraiva2 and Catarina S Guerreiro 1,2
1Escola Superior de Tecnologia da Saúde de Lisboa, Portugal
2University of Lisbon, Portugal
3Universidade de Évora, Portugal
4Centro de Investigação em Desporto, Saúde e desenvolvimento Humano, Portugal
Fibromyalgia (FM) is a chronic disease of unknown aetiology, characterized by widespread myofascial pain and reduction in
quality of life (QOL). FM and Irritable Bowel Syndrome (IBS) are frequently found to be overlapping “sensory sensitivity
syndromes”. To date, pharmacotherapy has had limited therapeutic efficacy in treatment of FM. There is growing evidence that
diets low in FODMAPs (fermentable oligo-di- and mono- saccharides and polyols) are effective in reducing IBS symptoms.
We investigated if a balanced low FODMAP diet (LFD) could reduce FM and GI symptoms and improve QOL (Quality of
Life). We conducted a longitudinal study of LFD intervention using a four-week, repeated-assessment model. Initially, clinical
assessments were made and participants presented LFDs. Following LFD treatment, we assessed any effects and reintroduced
FODMAPs to the diets. We then conducted final assessments and provided nutritional counselling. Assessment tools included:
Revised Fibromyalgia Impact Questionnaire (RFIQ: 0-100), Fibromyalgia Survey Questionnaire (FSQ: 0-31), Severity Score
System (IBS-SSS: 0-500), Euro-Quality of Life (QOL: 0-100), and Clinical Outcomes Routine Evaluation (Core-OM: 0-4). The
cohort included 38 women, mean age 51 years, with 10 years of FM. Initial assessments showed scores for severity of FM of
22±4.4, RFIQ 65±17, IBS-SSS 275±101, and QOL 48±19. There was 86% adherence to LFD diets accompanied by a significant
(p<0.01) reduction of FODMAPs intake, from 25 g/day to 2.5 g/day. Follow-up assessments showed significant reductions
in VAS Pain (Visual Analogue Scale) FSQ and RFIQ scores (p<0.01). Severity of GI symptoms was reduced by 50% with a
significant reduction of IBS-SSS to 132±117. Improvements in FM and gastrointestinal scores were significantly correlated
(r=0.36; p<0.05) and adherence to diet was significantly correlated with “satisfaction with the improvement” (r=0.65; p<0.01).
This pilot study shows that GI and pain symptoms associated with FM can be reduced by restricting FODMAPs. A more
comprehensive study of diet therapy for treatment of FM is warranted.
J Pain Relief 2017, 6:5(Suppl)
DOI: 10.4172/2167-0846-C1-015